Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 40,000 KRW
Change Today +1,250 / 3.23%
Volume 194.5K
As of 2:21 AM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

macrogen inc (038290) Snapshot

Open
38,850
Previous Close
38,750
Day High
40,250
Day Low
38,550
52 Week High
04/17/15 - 45,750
52 Week Low
07/16/14 - 23,900
Market Cap
355.8B
Average Volume 10 Days
328.4K
EPS TTM
344.00
Shares Outstanding
8.9M
EX-Date
--
P/E TM
116.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for MACROGEN INC (038290)

Related News

No related news articles were found.

macrogen inc (038290) Related Businessweek News

No Related Businessweek News Found

macrogen inc (038290) Details

Macrogen Inc. provides genome research solutions in South Korea and internationally. The company operates through Sequencing, Oligo, Biochip, Transgenic & Knockout Mouse, and Bioinformatics divisions. The Sequencing division provides standard, difficult template, EZ, and 16s rRNA sequencing services, as well as primer walking, microsatellite analysis, and cloning services. The Oligo division offers DNA synthesis services, including MOPC purification services. Its Biochip division develops and offers various DNA Chip products comprising MacArray Express Oligochip to identify the degree of gene expression; and MacArray Karyo for diagnosing human chromosome aberration, as well as designs and produces MacProbe consisting of various fish probe products. The Transgenic & Knockout Mouse division produces and supplies transgenic mice for use in the research on gene functions; and knockout mice to obtain an organism that demonstrates a new character by knocking out a specific gene. This division also offers mouse breeding and pedigree maintenance, specific pathogen free mouse production and management, and embryo freezing services. The Bioinformatics division provides database construction, genome research, and bioinformatics analysis system consulting services. Macrogen, Inc. was founded in 1997 and is based in Seoul, South Korea.

Founded in 1997

macrogen inc (038290) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

macrogen inc (038290) Key Developments

Macrogen Enters Exome Sequencing Analysis Service Provision Agreement with University College London

Macrogen has announced that the company has entered into a genome analysis service provision agreement with University College London continuing from 2014. To enter this year's provision agreement, Macrogen competed against multiple genome analysis service providers according to the designated competition agreement process hosted by UCL. By achieving outstanding assessments in data analysis, service quality, and reliability, Macrogen was selected as the final service provider for the second year in a row. Through this agreement, Macrogen will provide exome sequencing service for neurodegenerative disease samples to the UCL Institute of Neurology. UCL is currently operating a project to identify genetic causation and risk factors for Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases by collecting samples from collaborating institutions in the United States and across Europe.

Macrogen Inc. Proposes Some Changes to Articles of Incorporation

Macrogen Inc. announced that it will approve some changes in article of incorporation in the annual general meeting to be held on March 27, 2015.

Macrogen Inc., Annual General Meeting, Mar 27, 2015

Macrogen Inc., Annual General Meeting, Mar 27, 2015., at 09:00 Korea Standard Time. Location: 9th Floor, 254 (Dong, World Meridian Venture Center 1st) Macrogen. Agenda: To consider and reporting requirements of the 19 audit reports and audit committee report based sales 19 group financial statements and the consolidated financial statements; to consider the articles of Incorporation, some changes; to consider the senior director Kim Na- yeon; to consider the stock options granted; and to consider the approval of director remuneration.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
038290:KS 40,000.00 KRW +1,250

038290 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 038290.
View Industry Companies
 

Industry Analysis

038290

Industry Average

Valuation 038290 Industry Range
Price/Earnings 100.0x
Price/Sales 5.8x
Price/Book 5.0x
Price/Cash Flow 90.9x
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MACROGEN INC, please visit www.macrogen.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.